Integrative multi-omics approach for identifying molecular signatures and pathways and deriving and validating molecular scores for COVID-19 severity and status
| dc.contributor.author | Lipman, Danika | |
| dc.contributor.author | Safo, Sandra E. | |
| dc.contributor.author | Chekouo, Thierry | |
| dc.date.accessioned | 2023-06-18T00:02:44Z | |
| dc.date.available | 2023-06-18T00:02:44Z | |
| dc.date.issued | 2023-06-12 | |
| dc.date.updated | 2023-06-18T00:02:44Z | |
| dc.description.abstract | Abstract Background There is still more to learn about the pathobiology of COVID-19. A multi-omic approach offers a holistic view to better understand the mechanisms of COVID-19. We used state-of-the-art statistical learning methods to integrate genomics, metabolomics, proteomics, and lipidomics data obtained from 123 patients experiencing COVID-19 or COVID-19-like symptoms for the purpose of identifying molecular signatures and corresponding pathways associated with the disease. Results We constructed and validated molecular scores and evaluated their utility beyond clinical factors known to impact disease status and severity. We identified inflammation- and immune response-related pathways, and other pathways, providing insights into possible consequences of the disease. Conclusions The molecular scores we derived were strongly associated with disease status and severity and can be used to identify individuals at a higher risk for developing severe disease. These findings have the potential to provide further, and needed, insights into why certain individuals develop worse outcomes. | |
| dc.identifier.citation | BMC Genomics. 2023 Jun 12;24(1):319 | |
| dc.identifier.uri | https://doi.org/10.1186/s12864-023-09410-5 | |
| dc.identifier.uri | https://hdl.handle.net/1880/116629 | |
| dc.identifier.uri | https://dx.doi.org/10.11575/PRISM/41472 | |
| dc.language.rfc3066 | en | |
| dc.rights.holder | The Author(s) | |
| dc.title | Integrative multi-omics approach for identifying molecular signatures and pathways and deriving and validating molecular scores for COVID-19 severity and status | |
| dc.type | Journal Article |